Phytochem Remedies IPO Alert: Rs 38 Cr Public Offer Opens Dec 18 – Can This Box Maker Be Your Next Multibagger?

Phytochem Remedies Gears Up for IPO on BSE SME Platform

Phytochem Remedies (India) Limited, a Jammu-based manufacturer of corrugated boxes and boards, is set to launch its Initial Public Offering (IPO) on the BSE SME platform. The IPO, opening on December 18 and closing on December 22, 2025, aims to raise approximately ₹38.22 crore. This fundraising initiative is crucial for the company's expansion plans, including purchasing new equipment, financing construction, repaying loans, and supporting general corporate needs.

The company, established in 2002, has a significant presence in the packaging industry, serving sectors like food and beverages, FMCG, pesticides, pharmaceuticals, and automotive. With two operational units in Bari Brahmana, Jammu, Phytochem Remedies has been demonstrating consistent growth in revenue and profitability.

The Core Issue

Phytochem Remedies (India) Limited has carved a niche in the packaging sector by manufacturing a range of corrugated products. Their portfolio includes 3-ply, 5-ply, and 7-ply corrugated boxes, alongside printed boxes, rolls, pads, and sheets. The company operates from two substantial facilities in Jammu, with Unit 1 occupying 43,360 square feet and Unit 2 an expansive 173,440 square feet, though a significant portion of the space remains to be utilized. As of September 30, 2025, the company’s workforce comprised 51 dedicated employees.

Financial Implications

The company's financial performance shows a clear upward trend. In the financial year 2023, Phytochem Remedies reported a total revenue of ₹20.83 crore and a net profit after tax of ₹0.82 crore. This grew to ₹32.90 crore in revenue and ₹2.31 crore in net profit for FY 2024. For FY 2025, revenue reached ₹36.81 crore with a net profit of ₹4.48 crore. In the period ending September 30, 2025 (part of FY 2026), the company posted revenues of ₹25.01 crore and a net profit of ₹3.75 crore, achieving a healthy net profit margin of 14.99%. This consistent year-on-year growth in both top-line and bottom-line figures highlights the company's operational efficiency and market demand.

IPO Information

The upcoming IPO will offer 3,900,000 equity shares of face value ₹10 each at a premium price of ₹98 per share. The total issue size stands at ₹38.22 crore, with the listing scheduled on the BSE SME platform. The market lot size for this IPO is fixed at 1,200 shares, requiring retail investors to apply for at least two lots. Mefcom Capital Markets Limited is serving as the lead manager for this public issue.

Impact

The successful completion of this IPO will provide Phytochem Remedies (India) Limited with the necessary capital to fuel its growth trajectory. The investment in new machinery and infrastructure is expected to enhance production capacity and efficiency. Repaying existing loans could improve the company's financial health and reduce interest burdens. For investors, this IPO presents an opportunity to participate in the growth of a manufacturing company in the burgeoning packaging sector. The BSE SME platform is designed for small and medium enterprises, offering a stepping stone to the main board.

Impact Rating: 6/10

Difficult Terms Explained

• IPO (Initial Public Offering): The first time a private company offers its shares to the public.
• BSE SME Platform: A dedicated trading platform on the Bombay Stock Exchange for small and medium-sized enterprises to raise capital.
• Corrugated boxes and boards: Packaging materials made from fluted paperboard, commonly used for shipping and protection.
• FMCG (Fast-Moving Consumer Goods): Everyday items like packaged foods, toiletries, and beverages that sell quickly.
• Tax: A compulsory financial charge imposed by a government.
• Prospectus: A formal legal document providing details about an investment offering for potential investors.